Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
TuHURA Biosciences, Inc. - Common Stock
(NQ:
HURA
)
4.480
+0.480 (+12.00%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,294,289
Open
4.070
Bid (Size)
4.010 (1)
Ask (Size)
4.280 (8)
Prev. Close
4.000
Today's Range
3.800 - 4.550
52wk Range
2.920 - 7.930
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTS and HURA on Behalf of Shareholders
December 20, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE, ML, HURA, KANT on Behalf of Shareholders
December 18, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
Performance
YTD
-28.89%
-28.89%
1 Month
+33.73%
+33.73%
3 Month
-28.89%
-28.89%
6 Month
-28.89%
-28.89%
1 Year
-28.89%
-28.89%
More News
Read More
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ML, PDCO, HURA, KANT on Behalf of Shareholders
December 14, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
December 12, 2024
Via
ACCESSWIRE
TuHURA Biosciences (NASDAQ:HURA) to Present at the Virtual Investor "New to the Street" Event
October 22, 2024
Via
ACCESSWIRE
HURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of TuHURA Biosciences, Inc. Is Fair to Shareholders
December 12, 2024
From
Halper Sadeh LLC
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 27, 2024
Via
Benzinga
TuHURA Biosciences, Inc. (Nasdaq: HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastatic Merkel Cell Carcinoma and Provides Business Update
November 25, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
October 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 21, 2024
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.